Xiaoyaosan Ameliorates Chronic Restraint Stress-Induced Depression-Like Phenotype by Suppressing A2AR Signaling in the Rat Striatum

被引:11
作者
Zhu, Xiaoxu [1 ,2 ]
Ma, Qingyu [1 ]
Yang, Furong [3 ]
Li, Xiaojuan [1 ]
Liu, Yueyun [4 ]
Chen, Jianbei [4 ]
Li, Lan [2 ]
Chen, Man [2 ]
Zou, Xiaojuan [2 ]
Yan, Li [1 ]
Chen, Jiaxu [1 ,4 ]
机构
[1] Jinan Univ, Formula Pattern Res Ctr, Sch Tradit Chinese Med, Guangzhou Key Lab Formula Pattern Tradit Chinese M, Guangzhou, Peoples R China
[2] Hubei Univ Chinese Med, Sch Basic Med Sci, Wuhan, Peoples R China
[3] Hubei Minzu Univ, Med Sch, Enshi, Peoples R China
[4] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China
基金
美国国家科学基金会; 中国国家自然科学基金;
关键词
xiaoyaosan; depression; chronic restraint stress; adenosine receptor; microglia activation; ADENOSINE A(2A) RECEPTORS; ACTIVATION; MODULATE; ROLES; MODEL;
D O I
10.3389/fphar.2022.897436
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Depression is a common mental disorder characterized by pessimism and world-weariness. In our previous study, we found that Xiaoyaosan (XYS) could have antidepressive effects, however the underlying mechanisms remain unclear. Several studies have shown that adenosine A (2 A) receptor (A2AR) in the brain is a key point in the treatment of depression. Our present study aimed to investigate the effects of XYS on A2AR signaling in the striatum of rats exposed to chronic restraint stress (CRS). Ninety-six male Sprague-Dawley rats were randomly divided into 8 groups (control, model, negative control, XYS, A2AR antagonist, A2AR antagonist + XYS, A2AR agonist, A2AR agonist + XYS). The rats in the model group, XYS group, A2AR antagonist group and A2AR antagonist + XYS group were subjected to CRS for 3 h a day. The XYS decoction [2.224 g/(kg center dot d)] was intragastrical administered by oral gavage to the rats in the negative control group, XYS group, A2AR antagonist + XYS group, and A2AR agonist + XYS group. The rats in the A2AR antagonist group and A2AR antagonist + XYS group were treated with SCH 58261 [0.05 mg/(kg center dot d)], and the rats in the A2AR agonist and A2AR agonist + XYS group were treated with CGS 21680 [0.1 mg/(kg center dot d)]. These procedures were performed for 21 consecutive days. Behavioral studies including the open field test, elevated plus maze test, sucrose preference test and forced swimming test, were performed to examine depression-like phenotypes. Then, the effects of XYS on CRS- or A2AR agonist-induced striatal subcellular damage, microglial activation and A2AR signaling changes in the striatum were examined. Here, we report that XYS ameliorates depression-like phenotypes (such as body weight loss as well as depression- and anxiety-like behaviors) and improves synaptic survival and growth in the stratum of the CRS rats. Moreover, XYS reduces A2AR activity and suppresses hyper-activation of striatal microglia. The tissue and cellular effects of XYS were similar to those of the known A2AR antagonists. In conclusion, XYS alleviates depression in the CRS rats via inhibiting A2AR in the striatum.
引用
收藏
页数:13
相关论文
共 51 条
[1]   Dopaminergic Enhancement of Striatal Response to Reward in Major Depression [J].
Admon, Roee ;
Kaiser, Roselinde H. ;
Dillon, Daniel G. ;
Beltzer, Miranda ;
Goer, Franziska ;
Olson, David P. ;
Vitaliano, Gordana ;
Pizzagalli, Diego A. .
AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (04) :378-386
[2]   Central nervous system myeloid cells as drug targets: current status and translational challenges [J].
Biber, Knut ;
Moeller, Thomas ;
Boddeke, Erik ;
Prinz, Marco .
NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (02) :110-124
[3]   Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation [J].
Borroto-Escuela, Dasiel O. ;
Hinz, Sonja ;
Navarro, Gemma ;
Franco, Rafael ;
Mueller, Christa E. ;
Fuxe, Kjell .
FRONTIERS IN NEUROSCIENCE, 2018, 12
[4]   Adenosine A1 receptors modulate the Na+-Hypertonicity induced glutamate release in hypothalamic glial cells [J].
Braga, Danielle Valente ;
Wanderley Picanco-Diniz, Domingos Luiz ;
Herculano Matos Oliveira, Karen Renata ;
Luz, Waldo Lucas ;
Soares de Moraes, Suellen Alessandra ;
Fonseca Passos, Adelaide C. ;
Oliveira Batista, Evander de Jesus ;
Grisolia, Alan ;
Herculano, Anderson Manoel .
NEUROCHEMISTRY INTERNATIONAL, 2019, 126 :64-68
[5]   Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer [J].
Colucci-D'Amato, Luca ;
Speranza, Luisa ;
Volpicelli, Floriana .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) :1-29
[6]   Enhanced role of adenosine A2A receptors in the modulation of LTP in the rat hippocampus upon ageing [J].
Costenla, Ana R. ;
Diogenes, Maria J. ;
Canas, Paula M. ;
Rodrigues, Ricardo J. ;
Nogueira, Celia ;
Maroco, Joao ;
Agostinho, Paula M. ;
Ribeiro, Joaquim A. ;
Cunha, Rodrigo A. ;
de Mendonca, Alexandre .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2011, 34 (01) :12-21
[7]   Microglial activation and its implications in the brain diseases [J].
Dheen, S. Thameem ;
Kaur, Charanjit ;
Ling, Eng-Ang .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (11) :1189-1197
[8]   Effect of Xiaoyaosan on Colon Morphology and Intestinal Permeability in Rats With Chronic Unpredictable Mild Stress [J].
Ding, Fengmin ;
Wu, Jiajia ;
Liu, Chenyue ;
Bian, Qinglai ;
Qiu, Wenqi ;
Ma, Qingyu ;
Li, Xiaojuan ;
Long, Man ;
Zou, Xiaojuan ;
Chen, Jiaxu .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[9]   The Kaleidoscope of Microglial Phenotypes [J].
Dubbelaar, Marissa L. ;
Kracht, Laura ;
Eggen, Bart J. L. ;
Boddeke, Erik W. G. M. .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[10]   Psychotic Depression: Diagnosis, Differential Diagnosis, and Treatment [J].
Dubovsky, Steven L. ;
Ghosh, Biswarup M. ;
Serotte, Jordan C. ;
Cranwell, Victoria .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2021, 90 (03) :160-177